Total Payments
$3,984
2024 Payments
$1,246
Companies
14
Transactions
122
Medicare Patients
3,977
Medicare Billing
$382,880
Payment Breakdown by Category
Food & Beverage$3,159 (79.3%)
Consulting$825.00 (20.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,159 | 121 | 79.3% |
| Consulting Fee | $825.00 | 1 | 20.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,098 | 54 | $0 (2023) |
| Gyrus ACMI, Inc. | $825.00 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $793.95 | 35 | $0 (2024) |
| Harmony Biosciences LLC | $545.41 | 14 | $0 (2022) |
| Inspire Medical Systems, Inc. | $207.36 | 4 | $0 (2024) |
| Kyowa Kirin, Inc. | $123.70 | 5 | $0 (2022) |
| Jazz Pharmaceuticals Inc. | $102.69 | 1 | $0 (2017) |
| IDORSIA PHARMACEUTICALS US INC | $81.17 | 1 | $0 (2023) |
| VIVUS LLC | $61.38 | 1 | $0 (2022) |
| ZOLL Respicardia, Inc. | $56.90 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,246 | 17 | Gyrus ACMI, Inc. ($825.00) |
| 2023 | $451.39 | 13 | AstraZeneca Pharmaceuticals LP ($161.56) |
| 2022 | $627.22 | 21 | Harmony Biosciences LLC ($253.49) |
| 2021 | $728.56 | 27 | GlaxoSmithKline, LLC. ($362.20) |
| 2020 | $461.72 | 21 | GlaxoSmithKline, LLC. ($335.41) |
| 2019 | $350.13 | 21 | GlaxoSmithKline, LLC. ($326.70) |
| 2017 | $119.75 | 2 | Jazz Pharmaceuticals Inc. ($102.69) |
All Payment Transactions
122 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $29.38 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $29.02 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $28.21 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: Respiratory | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: Respiratory | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug), TEZSPIRE | Food and Beverage | In-kind items and services | $8.02 | General |
| Category: Respiratory | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Respiratory | ||||||
| 08/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Respiratory | ||||||
| 07/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: Respiratory | ||||||
| 04/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $31.73 | General |
| Category: Respiratory | ||||||
| 03/13/2024 | Gyrus ACMI, Inc. | — | Consulting Fee | Cash or cash equivalent | $825.00 | General |
| 03/08/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $15.61 | General |
| Category: Respiratory | ||||||
| 02/01/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $36.52 | General |
| Category: NEUROLOGY | ||||||
| 02/01/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: NEUROLOGY | ||||||
| 01/22/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $55.01 | General |
| Category: NEUROLOGY | ||||||
| 11/02/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $93.23 | General |
| Category: NEUROLOGY | ||||||
| 10/18/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $33.26 | General |
| Category: Respiratory | ||||||
| 08/29/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2023 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $41.29 | General |
| Category: Respiratory | ||||||
| 07/12/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Respiratory | ||||||
| 06/29/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: IMMUNOLOGY | ||||||
| 06/15/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Respiratory | ||||||
| 05/30/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,060 | 1,307 | $339,205 | $104,948 |
| 2022 | 9 | 987 | 1,256 | $318,300 | $95,977 |
| 2021 | 10 | 1,082 | 1,307 | $336,950 | $104,110 |
| 2020 | 9 | 848 | 1,110 | $285,300 | $77,844 |
Total Patients
3,977
Total Services
4,980
Medicare Billing
$382,880
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 506 | 703 | $175,707 | $58,130 | 33.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 112 | 112 | $44,836 | $13,836 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 108 | 149 | $29,662 | $7,916 | 26.7% |
| G0398 | Home sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation | Office | 2023 | 21 | 22 | $15,400 | $6,336 | 41.1% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 57 | 57 | $14,250 | $5,246 | 36.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 60 | 62 | $9,200 | $2,978 | 32.4% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 57 | 59 | $8,750 | $2,151 | 24.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 61 | 63 | $9,350 | $2,103 | 22.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 15 | 16 | $4,800 | $1,651 | 34.4% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 11 | 12 | $9,150 | $1,452 | 15.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 21 | 21 | $5,250 | $1,275 | 24.3% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 19 | 19 | $10,350 | $1,114 | 10.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,500 | $758.68 | 30.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 500 | 724 | $181,000 | $59,880 | 33.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 108 | 108 | $43,200 | $13,364 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 101 | 133 | $26,600 | $6,664 | 25.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 63 | 67 | $10,000 | $3,449 | 34.5% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 34 | 34 | $8,500 | $3,194 | 37.6% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2022 | 39 | 39 | $24,350 | $2,857 | 11.7% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 63 | 67 | $10,000 | $2,645 | 26.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 65 | 70 | $10,450 | $2,430 | 23.3% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 14 | 14 | $4,200 | $1,494 | 35.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 416 | 575 | $143,750 | $48,844 | 34.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 133 | 133 | $53,200 | $16,593 | 31.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 195 | 251 | $50,200 | $14,142 | 28.2% |
About Dr. Meena Mehta, MD
Dr. Meena Mehta, MD is a Pulmonary Disease healthcare provider based in Concord, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1285615310.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Meena Mehta, MD has received a total of $3,984 in payments from pharmaceutical and medical device companies, with $1,246 received in 2024. These payments were reported across 122 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($3,159).
As a Medicare-enrolled provider, Mehta has provided services to 3,977 Medicare beneficiaries, totaling 4,980 services with total Medicare billing of $382,880. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Concord, MA
- Active Since 11/07/2005
- Last Updated 05/01/2015
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1285615310
Products in Payments
- TRELEGY ELLIPTA (Drug) $773.14
- Wakix (Drug) $545.41
- BREZTRI (Drug) $273.87
- INSPIRE (Device) $207.36
- AIRSUPRA (Drug) $201.95
- ANORO (Drug) $138.19
- NUCALA (Biological) $110.30
- Xyrem (Drug) $102.69
- SYMBICORT (Drug) $101.24
- NOURIANZ (Drug) $97.16
- QUVIVIQ (Drug) $81.17
- ANORO ELLIPTA (Drug) $76.82
- QSYMIA (Drug) $61.38
- TEZSPIRE (Biological) $58.93
- remede System (Device) $56.90
- FASENRA (Biological) $47.56
- Nourianz (Drug) $26.54
- INBRIJA (Drug) $24.19
- FASENRA (Drug) $23.43
- Dhivy (Drug) $22.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Concord
Douglas Kelling, Md, MD
Pulmonary Disease — Payments: $253,797
Pulmonary Disease $253,797
John Hadley, M.d, M.D
Pulmonary Disease — Payments: $7,581
Pulmonary Disease $7,581
Hiromi Takekuma, D.o, D.O
Pulmonary Disease — Payments: $1,254
Pulmonary Disease $1,254
Richard Kops, M.d, M.D
Pulmonary Disease — Payments: $558.43
Pulmonary Disease $558.43
Sahar Mansoor, Md, MD
Pulmonary Disease — Payments: $410.04
Pulmonary Disease $410.04
Neha Mehta, Do, DO
Pulmonary Disease — Payments: $113.28
Pulmonary Disease $113.28